Tandem Diabetes' t:slim X2 pump with Control-IQ+ tech gains U.S. early access using FreeStyle Libre 3 Plus sensor.
Vous n'êtes pas connecté
The latest addition to TNDM's pump platform portfolio, Tandem Mobi, is leading the way in creating a whole new category of devices for insulin therapy.
Tandem Diabetes' t:slim X2 pump with Control-IQ+ tech gains U.S. early access using FreeStyle Libre 3 Plus sensor.
Tandem Diabetes' t:slim X2 pump with Control-IQ+ tech gains U.S. early access using FreeStyle Libre 3 Plus sensor.
Fujifilm is set to unveil the latest addition to its renowned continuous feed inkjet portfolio—the Jet Press 1160CF
Fujifilm is set to unveil the latest addition to its renowned continuous feed inkjet portfolio—the Jet Press 1160CF
Philip Morris Misr has announced the launch of IQOS ILUMA i in Egypt, the latest and most advanced addition to its portfolio of smoke-free products....
ABT rides on strong global demand in diagnostics and diabetes care, but macro headwinds may test its momentum ahead.
Statin therapy is a proven, safe, and cost-effective way to lower cholesterol and reduce cardiovascular risk. However, despite recommendations from...
Statin therapy is a proven, safe, and cost-effective way to lower cholesterol and reduce cardiovascular risk. However, despite recommendations from...
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.